Optimvia
Pre-clinicalOptimvia is a biopharmaceutical company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules. Our first breakthrough product using the ADEPT Platform is biosynthetic heparin. We have created new enzymes and a cofactor to recapitulate the natural synthesis of heparin.
Founded
2021
Focus
Biologics
About
Optimvia is a biopharmaceutical company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules. Our first breakthrough product using the ADEPT Platform is biosynthetic heparin. We have created new enzymes and a cofactor to recapitulate the natural synthesis of heparin.
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile